Verratti Mark 4

What Happened
Mark Verratti, Chief Operating Officer of Myriad Genetics (MYGN), had 1,069 shares of common stock withheld by the company on April 14, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The withholding was based on a $4.91 closing price, totalling approximately $5,249. This is a routine tax-withholding disposition rather than an open-market sale.

Key Details

• Transaction date and price: April 14, 2026 at $4.91 per share.
• Shares withheld/disposed: 1,069 shares; total value ≈ $5,249.
• Filing: Form 4 filed April 15, 2026 (reporting period April 14, 2026) — appears timely.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: F — Shares withheld by the issuer to satisfy tax withholding from RSU vesting; number withheld determined using the April 14, 2026 closing price.

Context: Tax-withholding dispositions for vested restricted stock units are common and administrative. They represent the company retaining shares to cover tax obligations (a cashless settlement) and are not a directional trade signal like an open-market purchase or sale.